Niaid.nih.gov

10255Nieuwsbrieven

0Abonnementen

Klik hier om u te abonneren op Niaid.nih.gov

Nieuwsbrieven

COVID-19 workers get training to protect their own health Niaid.nih.gov
4 jaren geleden
Director's Message: Navigating Challenging Times with Scientifically Sound Resources Niaid.nih.gov
4 jaren geleden
National Drug and Alcohol Facts Week celebrates 10 years Niaid.nih.gov
4 jaren geleden
Relief for Clinicians, Provider s, Hospitals and Facilities Part icipating in Quality Reporting Programs in Response to COVID-19 Niaid.nih.gov
4 jaren geleden
Trump Administration Releases COVID-19 Checklists and Too ls to Accelerate Relief for State Medicaid & CHIP Programs Niaid.nih.gov
4 jaren geleden
NHSC Application: Preparing Your Documents Niaid.nih.gov
4 jaren geleden
CMS Releases Telehealth Toolkits for General Practi tioners and End-Stage Renal Disease (ESRD) Providers Niaid.nih.gov
4 jaren geleden
HHS HIV/AIDS Guidelines Panels Release Inter im Guidance for COVID-19 and Persons with HIV Niaid.nih.gov
4 jaren geleden
NIH shifts non-mission-critical laborator y operations to minimal maintenance phase Niaid.nih.gov
4 jaren geleden
CMS Approves Washington States Request for 1135 Medicaid Waiver Niaid.nih.gov
4 jaren geleden
Medicaid and CHIP Agencies All State COVID-19 Stakeholder Call Recording & Transcript Posting Niaid.nih.gov
4 jaren geleden
NIH study provides genetic insig hts into osteosarcoma in children Niaid.nih.gov
4 jaren geleden
COVID-19 Resources for NIH Grantees and Applicants Niaid.nih.gov
4 jaren geleden
AIDSinfo Weekly Twitter Digest Update Niaid.nih.gov
4 jaren geleden
December 2019 Medicaid & CHIP Monthly Enrollment Report Niaid.nih.gov
4 jaren geleden
COVID-19, Taking on rural substance misuse, and more Niaid.nih.gov
4 jaren geleden
To Beat COVID-19, Social Distancing is a Must Niaid.nih.gov
4 jaren geleden
CMS COVID-19 Elective Surgeries and No n-Essential Procedures Recommendations Niaid.nih.gov
4 jaren geleden
CMS COVID-19 Catastrophic Health Coverage FAQs Niaid.nih.gov
4 jaren geleden
In NIH trial, selumetinib shrinks tumors, pr ovides clinical benefit for children with NF1 Niaid.nih.gov
4 jaren geleden

© 2024